HealthPartners Neuroscience Center Research and Innovation
Warning LetterOpen
Recipient Name Leah R. Hanson, Ph.D., Recipient Title Senior Director, Neuroscience Research, HealthPartners Neuroscience Center Research and Innovation, 295 Phalen Boulevard Saint Paul , MN 55130-2455 United StatesIssued May 19, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.
Violations4
Issue DateMay 19, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
HealthPartners Neuroscience Center Research and Innovation
Location
Recipient Name Leah R. Hanson, Ph.D., Recipient Title Senior Director, Neuroscience Research, HealthPartners Neuroscience Center Research and Innovation, 295 Phalen Boulevard Saint Paul , MN 55130-2455 United States
FEI Number
N/A
Country
United States
Issue Date
May 19, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies
HealthPartners Neuroscience Center Research and Innovation FDA Warning Letter, May 19, 2026
Talk to a Specialist